Business ❯ Investing ❯ Pharmaceuticals

Manufacturing

Eli Lilly Job Creation Johnson & Johnson AstraZeneca Roche Eli Lilly and Company U.S. Manufacturing Supply Chain Roche Holdings AG Facility Development Active Pharmaceutical Ingredients

Merck Breaks Ground on $3 Billion Virginia Plant in $70 Billion U.S. Expansion

Construction starts years before targeted manufacturing in 2029, followed by full supply operations in 2030.

AstraZeneca Breaks Ground on $4.5 Billion Virginia Plant With Expanded Cancer and Obesity Drug Production

Eli Lilly Chooses Houston for $6.5 Billion Plant to Produce APIs for Orforglipron and Other Drugs

J&J Commits $2 Billion to 10-Year Fujifilm Deal for North Carolina Biologics Hub

AbbVie to Build $195 Million API Facility in North Chicago

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030